شماره ركورد كنفرانس :
5339
عنوان مقاله :
Doxorubicin in Chemotherapy
پديدآورندگان :
Youzbashi Diba youzbashid@gmail.com Material Science and Engineering Department, Khajeh Nasir Toosi University of Technology , Siadati Mohammad. H. siadati@gmail.com Material Science and Engineering Department, Khajeh Nasir Toosi University of Technology
كليدواژه :
doxorubicin , cancer , chemotherapy , cardiotoxicity , therapeutic effects , side effects.
عنوان كنفرانس :
دوازدهمين كنفرانس بين المللي مهندسي مواد و متالورژي
چكيده فارسي :
Doxorubicin or Adriamycin is most commonly used to treat several types of cancers such as breast cancer, carcinomas, sarcomas and hematological cancers. A growing body of evidence supports the view that this drug can be a double-edge sword. Indeed, injury to nontargeted tissues often complicates cancer treatment by limiting therapeutic dosages of DOX and diminishing the quality of patients’ life during and after DOX treatment.
